The National Leprosy Eradication Programme (NLEP) in India aims to eliminate leprosy, prevent disabilities, and reduce stigma associated with the disease. Key components of the program include case detection and treatment, disability prevention and rehabilitation, information/education campaigns, and human resource training. The NLEP is decentralized and integrated into general healthcare. It focuses on early detection and treatment using multidrug therapy, as well as preventing disabilities through services like reconstructive surgery. Monitoring and evaluation involves routine reporting and field visits to track indicators like prevalence and detection rates.
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
National Leprosy Eradication Programme
Date of creation- Feb 2019
Authors - Dr. Madhushree Acharya, Junior Resident, Community Medicine and Family Medicine, AIIMS Bhubaneswar; Dr. Durgesh Prasad Sahoo, Senior Resident, Community Medicine and Family Medicine, AIIMS Bhubaneswar
Integrated Disease Surveillance Project (IDSP) was launched by Hon’ble Union Minister of Health & Family Welfare in November 2004 for a period upto March 2010. The project was restructured and extended up to March 2012. The project continues in the 12th Plan with domestic budget as Integrated Disease Surveillance Programme under NHM for all States with Budgetary allocation of 640 Cr.
A Central Surveillance Unit (CSU) at Delhi, State Surveillance Units (SSU) at all State/UT head quarters and District Surveillance Units (DSU) at all Districts in the country have been established.
Objectives:
To strengthen/maintain decentralized laboratory based IT enabled disease surveillance system for epidemic prone diseases to monitor disease trends and to detect and respond to outbreaks in early rising phase through trained Rapid Response Team (RRTs)
Programme Components:
Integration and decentralization of surveillance activities through establishment of surveillance units at Centre, State and District level.
Human Resource Development – Training of State Surveillance Officers, District Surveillance Officers, Rapid Response Team and other Medical and Paramedical staff on principles of disease surveillance.
Use of Information Communication Technology for collection, collation, compilation, analysis and dissemination of data.
Strengthening of public health laboratories.
NACP IV critical analysis , where we have given a brief idea about the burden of HIV/AIDs globally , National and statewise. Evolution of NACO and NACP under different phases. Current achievements and the indicator to monitor the progress
After the successful NSP 2017-2025,Goi is lauching NSP 2017-2025 for elimination of TB on 24th march( World TB day ) 2017. Module is on MOHFW site but i have try to keep it brief,hope its ll be useful specially for academic and administrative purposes.
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
National Leprosy Eradication Programme
Date of creation- Feb 2019
Authors - Dr. Madhushree Acharya, Junior Resident, Community Medicine and Family Medicine, AIIMS Bhubaneswar; Dr. Durgesh Prasad Sahoo, Senior Resident, Community Medicine and Family Medicine, AIIMS Bhubaneswar
Integrated Disease Surveillance Project (IDSP) was launched by Hon’ble Union Minister of Health & Family Welfare in November 2004 for a period upto March 2010. The project was restructured and extended up to March 2012. The project continues in the 12th Plan with domestic budget as Integrated Disease Surveillance Programme under NHM for all States with Budgetary allocation of 640 Cr.
A Central Surveillance Unit (CSU) at Delhi, State Surveillance Units (SSU) at all State/UT head quarters and District Surveillance Units (DSU) at all Districts in the country have been established.
Objectives:
To strengthen/maintain decentralized laboratory based IT enabled disease surveillance system for epidemic prone diseases to monitor disease trends and to detect and respond to outbreaks in early rising phase through trained Rapid Response Team (RRTs)
Programme Components:
Integration and decentralization of surveillance activities through establishment of surveillance units at Centre, State and District level.
Human Resource Development – Training of State Surveillance Officers, District Surveillance Officers, Rapid Response Team and other Medical and Paramedical staff on principles of disease surveillance.
Use of Information Communication Technology for collection, collation, compilation, analysis and dissemination of data.
Strengthening of public health laboratories.
NACP IV critical analysis , where we have given a brief idea about the burden of HIV/AIDs globally , National and statewise. Evolution of NACO and NACP under different phases. Current achievements and the indicator to monitor the progress
After the successful NSP 2017-2025,Goi is lauching NSP 2017-2025 for elimination of TB on 24th march( World TB day ) 2017. Module is on MOHFW site but i have try to keep it brief,hope its ll be useful specially for academic and administrative purposes.
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). By damaging your immune system, HIV interferes with your body's ability to fight infection and disease.
The National AIDS Control Programme (NACP), launched in 1992, is being implemented as a comprehensive programme for prevention and control of HIV/AIDS in India. Over time, the focus has shifted from raising awareness to behavior change, from a national response to a more decentralized response and to increasing involvement of NGOs and networks of PLHIV.
AIDS and its vengeance saw a back seat after we achieved the zero level of growth for it. But worries regarding the people living with AIDS are still on and we need to take care of these segments in an integrated manner
Presentation given at the launch of COUNTDOWN in CameroonCOUNTDOWN on NTDs
Providing an overview of progress and Neglected Tropical Diseases in Cameroon and highlighting future COUNTDOWN activities, this presentation was given at the launch in Cameroon.
Leprosy is an age-old disease and is described in the literature of ancient civilizations. It is a chronic infectious disease which is caused by a type of bacteria called Mycobacterium leprae. The disease affects the skin, the peripheral nerves, mucosa of the upper respiratory tract, and the eyes. Leprosy is curable and treatment in the early stages can prevent disability. Apart from the physical deformity, persons affected by leprosy also face stigmatization and discrimination
National Prioritized Disease Control Programs of Nepaljkrasik07
This is the extract of the various national prioritized control programs of Nepal containing data and progress regarding HIV/AIDS and STI, Tuberculosis, Malaria, Kala-Azar, Lymphatic Filariasis, Dengue, Leprosy and Immunization Programme. These slides contain data majorly from the Annual Health Report of 2078/79 (21/22) published by MoHP.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
3. INTRODUCTION
Beauty and purity in lotus
Leprosy can be cured and
leprosy patient can be a useful member
of the society in the form of a
partially affected thumb;
normal fore-finger and the shape of house;
Symbol of hope and optimism - rising
sun.
The Emblem captures the spirit of hope
positive action in the eradication of
Leprosy.
3
4. INTRODUCTION
Leprosy – oldest disease
"Kusht Rog”
Causative agent - Mycobacterium leprae bacillus
Mode of transmission - Airborne (droplet) dissemination, direct skin-to-
skin contact, mechanical transfer, inoculation.
"Chaulmoogra" oil
Sulfone drug, e.g. Dapsone was discovered in 1943
MultiDrugTreatment (MDT) - 1981
4
5. INTRODUCTION
oNational Leprosy Eradication Program (NLEP) in 1983
- Objective to arrest the disease activity in all the known cases of leprosy
oHeaded by the Deputy Director of Health Services (Leprosy )
oStrategies and plans formulated centrally
oSupported as Partners by the World Health Organization, The International
Federation of Anti-leprosy Associations (ILEP)
5
6. OBJECTIVES
Elimination of leprosy
Strengthen Disability Prevention & Medical Rehabilitation of
persons affected by leprosy.
Reduction in the level of stigma associated with leprosy.
6
7. MILESTONES
oThe Indian Council of the British Empire Leprosy Relief Association in 1925
oRenamed as Hind Kusht Nivaran Sangh in 1947
oNational Leprosy Control Program in 1955
oCentrally aided program for control through
– early detection of cases and
– treatment with Dapsone (DDS) monotherapy
o1981 - Leprosy eradication strategy planned
7
8. MILESTONES
1981 – definite cure = MDT
1983 - National Leprosy Eradication Programme launched
2005 - Elimination of Leprosy at National Level
2012 - Special action plan for 209 high endemic districts in 16
States/UTs
2016 - Leprosy Case Detection Campaign (LCDC) have begun
8
10. GLOBAL BURDEN-
2016
There were 2,16,108 new leprosy cases registered globally in 2016,
Based on 1,73,358 cases at the end of 2016, prevalence rate corresponds to 0.29/10,000.
10
11. PROBLEM STATEMENT-INDIA
The year 2016-17 started with 0.86 lakh leprosy cases on record
as on 1st April 2016, with PR 0.66/10,000.
Till then 34 States/ UTs had attained the level of leprosy
elimination.
554 districts (81.23%) out of total 682 districts also achieved
elimination by March 2017.
11
13. Table 1
NLEP REPORT
FOR THE YEAR
2016-17
13
Bihar
Chhattisgarh
Goa
Odisha
Chandigarh
D & N Haveli
Lakshadweep
14. FIG 1. TRENDS OF PREVALENCE RATE (PR) AND
ANNUAL NEW CASE DETECTION (ANCDR) (PER
10,000 POPULATION)
Note: The increase in new cases and prevalence during 2012-13 was
attributable to the NLEP strategy to carry out extensive house to house survey
for new case detection. Further increase in ANCDR during 2016-17 is
attributable to Leprosy case detection campaign.
14
16. KARNATAKA STATE BURDEN
Capital : BANGALORE
Districts : 30
Achieved the Goal of elimination in the year 2005
Estimated Population : 64805227 ( as on Mar 2015)
Leprosy PR : 0.42/10000 pop. (March 2015 )
Low endemic state up to end of 30/09/2015.
16
17. THE HINDU- KARNATAKA,
NOV 07, 2017.
17
Total number of cases (including new and on treatment) in 2017
till September = 2,501.
18. STRATEGY
• Decentralized integrated leprosy services through General
Health Care system
• Early detection and complete treatment of new leprosy cases
• Carrying out house to house contact survey for detection of MB
and child cases
• Early diagnosis and prompt MDT, through routine and special
efforts
18
19. STRATEGY
• Involvement of ASHAs in the detection and complete treatment
of leprosy cases for leprosy work
• Strengthening of Disability Prevention & Medical
Rehabilitation (DPMR) services
• IEC activities in the community to improve self-reporting to
PHC and reduction of stigma
• Intensive monitoring and supervision at PHC/ CHC
19
20. PROGRAMME COMPONENTS
Approved in the 12th Plan (2013 - 2017):
1. Case Detection and Management
2. Disability Prevention and Medical Rehabilitation
3. Information, Education and Communication (IEC) including
Behaviour Change Communication (BCC)
4. Human Resource and Capacity building
5. Programme Management
20
22. CASE DETECTION AND
MANAGEMENT
Stigma associated with the disease.
Cut down the transmission potential
(i) To improve access to services.
(ii) To involve women including leprosy affected persons in case
detection.
(iii) To organize skin camps.
(iv) To undertake contact survey to identify the source.
(v) To increase awareness, to suspect and motivate leprosy affected
persons for early reporting to the Medical Officer.
22
23. ASHA INVOLVEMENT
To bring out suspected cases for diagnosis
Follow up the patients for completion of treatment.
The ASHA will be entitled to receive incentive as below:
(i) At confirmation of diagnosis – Rs. 250/-
(ii) On completion of full course of treatment in time –
PB - additional Rs.400/
MB - additional Rs.600/-
23
24. NGO’S INVOLVEMENT
SET Scheme:
Disability prevention, ulcer care, Research.
IEC/BCC and stigma reduction
Referral of suspects, diagnosis and provision of MDT
Follow up of under treated cases.
DPMR
Referral for RCS
Conduct of RCS
24
25. ADDITIONAL ACTIVITIES IN
URBAN AREAS
(i) Identify human resources available for leprosy services.
(ii) Capacity building at time of induction.
(iii) Examination of all household contacts of all new cases at least once
before the completion of treatment of index case.
(iv) Identify one referral centre in each urban location for diagnosis and to
manage leprosy with or without complications.
(v) Supervision and monitoring of the programme.
25
26. (vi) Mobile Health Clinics with leprosy services.
(vii) System of record keeping and reporting.
(viii) System of regular MDT supply to Health Centre.
(ix) Procure additional requirement
(x) Organise sensitization meetings for IEC and advocacy, participate in
exhibitions, quiz competition for awareness to reduce stigma.
ADDITIONAL ACTIVITIES IN
URBAN AREAS
26
27. LEPROSY CASE DETECTION
CAMPAIGN (LCDC)
Implemented in high endemic districts
Monitored by CLD and coordinated by states
Online reporting system with patient tracking mechanism
(Nikusth)
GIS mapping to study and project geographic distribution of
disease
27
29. DISABILITY PREVENTION AND
MEDICAL REHABILITATION (DPMR)
All suspected cases of leprosy reaction, relapse, insensitive hands and feet
are referred to PHC for diagnosis.
The patient needs to be empowered in self-care to prevent worsening of
disability.
All PHC Medical Officers diagnose cases of reaction and treat them.
Severe reaction cases may be referred to the District Hospital, if not
responded within 2 weeks of starting treatment.
29
30. DISABILITY PREVENTION
Service and care for disabilities at all the Health Institutions.
Complicated ulcer cases are referred to District Hospital.
Microcellular Rubber (MCR) footwear - by the District cell through
PHC/CHC.
PHCs - follow up treatment to all patients referred back by the secondary
and tertiary level units for reaction, complication or post-surgery care.
30
31. MEDICAL REHABILITATION
SERVICES
Patients with grade II disability diagnosed at the PHC are referred to the
district hospital/ district cell
Cases suitable for reconstructive surgery (RCS) are referred to RCS
centers recognized by Govt. of India in Govt. or NGO sector.
Aids and appliances for medical rehabilitation are supplied to the patients.
Disability care services
31
33. QUALITY INDICATOR FOR RCS
SURGERY
The cohort analysis report, at quarterly interval
Proportion of Operated Cases with Improved Functional
Ability.
It can be calculated as:
Number of cases with improved functional ability
at 6 months after operation × 100
Number of cases operated
upon during the cohort period
33
34. INCENTIVE
to Patient :
Rs. 8,000/- - major RCS - District Leprosy Officer
to Institutions :
(a) To all Govt. Institutions - Rs. 5000 per RCS.
(b) To all Govt. Hospitals/Institutions, providing RCS in
camps organised outside the Institution, an
additional amount of Rs. 5000 per RCS will be
paid.
34
36. INFORMATION, EDUCATION AND
COMMUNICATION (IEC/BCC)
Focus on communication for behavioral changes in the general
public.
Objectives of IEC :-
To develop communication material.
To complement and support the detection and treatment services
To remove stigma.
Active participation of communities
36
37. INTERPERSONAL COMMUNICATION
Priority Areas:
Low literacy rates.
Tribal population
Endemic districts (ANCDR
>10/100,000 pop.).
Urban areas with problem of
migration.
Target groups:
Women from the areas where
literacy rate is low.
School children
Population groups residing in
remote inaccessible areas;
Tribal population.
Migratory population.
People living in urban slums.
Through the health staff involving communities, panchayat leaders and NGO.
37
38. INTER PERSONAL COMMUNICATION
Women mobilization
Old Leprosy Peoples’ association
Complain mechanism - toll free number
Use of IVRS (interactive voice recognition system)
38
39. NLEP-GUIDELINES ON REDUCTION OF
STIGMAAND DISCRIMINATION AGAINST
PERSONS AFFECTED BY LEPROSY
Objective :-
Provide at one place, the facts about stigma against leprosy, its
various determinants and types
Indicate intervention strategies to be followed under NLEP
Suggest line of action to be taken by the states/Uts
39
40. INTERVENTION STRATEGIES
Spreading awareness:
Developing understandings & concepts based on scientific knowledge
Preventing iatrogenic stigma
Involving communities/societies
Some interventions
empowerment, counseling and education.
40
41. INDICATORS FOR MONITORING
BCC ACTIVITIES
1. New Case Detection Rate and Proportion of Early case detection
in voluntary reported
2. Proportion of gr. ii disability among new cases
3. Treatment Completion Rates in predefined areas
4. Number of cases availed Rehabilitation services
5. Number of cases reported / noticed discrimination.
6. Number of cases (under care) developed new disability
7. Number of group meetings (IPC) held.
41
42. “LEPROSY FREE INDIA”
IEC Campaign Fortnight organized every year from 30th January,
Observed as Anti Leprosy Day in the country.
The following activities are to be carried out during this campaign:
Mass publicity to improve early reporting of cases
Capacity building of health staff including ASHAs and volunteers
Intensive case detection drives
Activities to reduce stigma and discrimination
Participation of persons affected by leprosy
42
44. HUMAN RESOURCE AND
CAPACITY BUILDING
The learning materials for training large number of GHC staff
were modified, shortened to 3 days duration
Learning material was also prepared and used for ASHAs
training.
A revised training manual also prepared for Medical Officers and
supplied to all States/UTs.
DPMR component major focus in all
Training for Health Supervisors (Male & Female) and Health
Workers (Male & Female) - every year.
44
46. PROGRAMME MANAGEMENT
Supervision and Travel cost
Services through the General Health care system with supervisory
support from the District cell.
Supervisory visits - Central/State level officers & experts from
other organization.
46
47. PROGRAMME MANAGEMENT
Programme Appraisal
Programme monitored through analysis of routine reports and
through field visits by the supervisory officers.
Programme Appraisal by a committee of experts identified by
Central Leprosy Division will be undertaken during the 2nd and
the 4th year of the 12th Plan.
Annual Programme Assessment
Performance under the programme assessed annually by an
Independent expert group.
47
48. PROGRAMME MANAGEMENT
National Sample Survey
to assess the leprosy incidence in the country along with the
disability load and IEC status, in the year 2015-16.
Inter personal communication –
The effective way to deal with difficult challenge of stigma
removal is to embark on intensive interpersonal communication
(IPC) with the target groups.
48
51. MONITORING AND EVALUATION
Simplified information system: indicators :
Prevalence rate of leprosy,
New case detection rate,
Child proportion among new cases,
Visible deformed case proportion among new cases,
MB proportion among new cases.
51
52. Female proportion among new cases,
New cases detection rate in scheduled castes,
New cases detection rate in scheduled tribes,
Patient month blister calendar packs stock,
Proportion of health sub-centers providing MDT; and
Absolute number of patients made RFT should also be
monitored.
52
MONITORING AND EVALUATION
53. Monthly report form for PHC/Hospital and Dispensary and for
district and state:
Patient Care Card,
Patient Treatment Record and
MDT Drug stock register.
Report and receipts examined by the concerned official at the level
of block PHC, District, State and Center.
53
MONITORING AND EVALUATION
54. BRIEF ABOUT NEWER
INDICATORS UNDER NLEP
• Main or Core indicators
– New case detection rate
– Treatment completion rate.
• Epidemiological indicators.
– Disability proportion
– MB case proportion
– Child proportion
55
55. OTHER INITIATIVES
Newsletters – Jan 2016
Nikusht
GIS mapping
Uniform multidrug therapy regimen
Mass drug administration
56
56. INSTITUTIONS
Four premier Leprosy Institutes
Working under Directorate General of Health Services, Ministry of
Health & F.W., Government of India
Purpose :
Research (basic and applied ) in Leprosy and
Training of different categories of staff
Management of referral patients,
Providing quality care
Supervising and providing consultancy services to the State NLEP Units.
57
58. GLOBAL LEPROSY STRATEGY
2016–2020
“Accelerating towards a leprosy-free world” - 20 April 2016.
Goal :
Further reduce the burden of leprosy
Comprehensive and timely care following the principles of equity and
social justice.
Purpose :
provide guidance for managers of national leprosy programmes (or
equivalent entities) to adapt and implement the Global Leprosy Strategy
in their own countries.
Structure : three strategic pillars
59
61. THE FINAL PUSH STRATEGY
FOR ELIMINATION OF LEPROSY
• Expand MDT services to all health facilities
• Ensure that all existing and new cases are given appropriate MDT
regimens
• Encourage all patients take treatment regularly and completely
• Promote awareness in the community on leprosy
• Set targets and time table for activities
• Keep good records of all activities - monitor the progress.
62
62. REFERENCES
Regional Office for South-East Asia, World Health Organization. (2017). Global Leprosy
Strategy 2016–2020. Accelerating towards a leprosy-free world. Monitoring and Evaluation
Guide. World Health Organization. Regional Office for South-East
Asia. http://www.who.int/iris/handle/10665/254907. License: CC BY-NC-SA 3.0 IGO
Kishore J. National Health Programs Of India: National Vector Borne Disease Control
Programme. 12th edition
Park K. Textbook of Preventive and Social Medicine: National Health Programs. 24th edition.
National Leprosy Eradication Programme (NLEP)Training Manual for Medical Officer. Central
Leprosy Division, Directorate General of Health Services Nirman Bhawan, New Delhi.
www.nlep.nic.in
Karnataka - National Leprosy Eradication Programme (NLEP); nlep.nic.in/karnataka.html
Karnataka - Latest news, Live Updates, Politics, Events - The Hindu;
www.thehindu.com/news/national/karnataka/
K. Park; textbook of preventive and social medicine; 24th edition.
Textbook of public health & community medicine 1st edition; AFMC Pune (2009); Ashok K.
Jindal, Puja Dudeja.
https://scroll.in/pulse/808951/the-world-wont-be-free-of-leprosy-unless-india-delivers
63
Editor's Notes
• No data were available regarding the prevalence of leprosy prior to 1955– Leprosy Control Units (LCU) and– Survey, Education and Treatment (SET) centres were set up in each district starting from 1955.– These conducted surveys for detecting cases of leprosy and provided data for the program– In addition these conducted IEC and provided treatment to the cases detected• In 1980 - It was made a centrally-sponsored programme
i.e. prevalence of less than 1 case per 10,000 population in all districts of the country.
As on 31st December 2005, Prevalence Rate recorded in the country was 0.95/10,000 population
according to official figures from 145 countries from the 6 WHO Regions.
At Present there are 2448 on hand. So far 562430 cases have been cured with MDT since 1986.
Current Strategy (under XII plan)
The involvement of ASHAs will be monitored by the concerned PHC Medical Officers. Records of cases referred by ASHAs will be maintained properly and incentive will be paid on time and regular monthly report will be submitted to the District Leprosy Officer
54/290 NGO’s get grant in aid from GOI
Objective is to provide uniformity in diagnosis, treatment and monitoring through a wider programme base to maximize access to NLEP services.
Survey, education and treatment scheme – 2006-7
Supervision and monitoring of the programme is the responsibility of the District Leprosy Officer, and Medical Officer of the referral centre.
of drugs, dressing material, aids and appliances for inhabitants of leprosy colony requiring regular care for their disabilities.
This should help in early data analysis, prompt feedback for action.
The services under DPMR will cover reaction management, self-care practices, provision of MCR Footwear, Aids & Appliances, referral services at District Hospitals and Medical Colleges/Central leprosy/ NGO Institutions including reconstructive surgery.
Referral centres will be developed depending on the need, in all district hospitals and Medical colleges. The referral centres will be supported by Dermatologists/Physicians of the district hospital and a Physiotherapist. Posting of one Physiotherapist for each District Hospital in identified high endemic districts has been approved on contract basis during the 12th Plan period.
such as ulcers, cracks and wounds, septic hand or feet etc. are available
Objectives of IEC :-
To develop communication material vis-à-vis the target audiences and deliver effectively.
To complement and support the detection and treatment services being provided free of cost through the General Health Care System.
To remove stigma associated with leprosy and prevent discrimination against leprosy affected persons.
To specifically cover beneficiaries, health providers, influencers and the masses.
The effective way to deal with difficult challenge of stigma removal is to embark on intensive inter-personal communication (IPC) with the target groups.
Spread the demystifying messages and its interpretations, mainly regarding nature of disease, whether hereditary, whether leprosy cases are touchable, role of immunity in occurrence of leprosy, what is burnt out case and so on. However, mere information and education, to all and sundry about the signs and symptoms of leprosy and its curability, shall not work. It is imperative to break the barrier between persons affected by leprosy and the rest of the society, by appealing to peoples‟ emotions and their ability to empathise with those they feared and shunned.
Central – channels and all india radio
State – mass media. Outdoor media, rural media, advocacy
Target audiences: selected communities with deep rooted stigma, leprosy affected person, general health care staff, ngo’s and community based organisations, disabled peoples organisations.
General health care
While regular State Govt. staff & experts will be drawing their TA/DA from the source of their salary, but contractual staff like surveillance Medical Officer, district leprosy consultant etc. will be paid from the programme budget. Similarly travel will be made by the consultants from the Central Leprosy Division to various States/UTs.
Disability proportion• It is the percentages of people with grade I and grade II disability among the new leprosy cases detected during the reporting year and for whom a disability assessment was carried out
to chronic ulcer and disabled patients with the help of Minor & Major Reconstructive Surgeries.
Central leprosy teachning & research institute (CLTRI) CHENGALPATTU (TAMILNADU)
Regional leprosy training & research institue (RLTRI) RAIPUR (CHHATTISGARGH)
Regional leprosy traning & research institute(RLTRI) ASKA (ORISSA)
Regional leprosy training & research institute RLTRI, GOURIPUR, BANKURA (WEST BENGAL)
i) strengthen government ownership and partnerships; ii) stop leprosy and its complications; and iii) stop discrimination and promote inclusion.
Adapting the suggested actions to national contexts will help countries to reach the global targets set for the year 2020. The Operational Manual has been developed by the World Health Organization with inputs from various core stakeholders such as national programme managers, technical agencies, funding agencies and nongovernmental organizations.
30th jan 2017 – sparsh campaign
so that individuals with suspicious lesions will report voluntarily for diagnosis and treatment